Created at	Source	Raw Value	Validated value
April 8, 2022, 3:30 p.m.	oms	The primary efficacy endpoint is the proportion of participants developing COVID-19 (laboratory confirmed SARS-CoV-2 infection with symptoms) through Day 14	The primary efficacy endpoint is the proportion of participants developing COVID-19 (laboratory confirmed SARS-CoV-2 infection with symptoms) through Day 14